Roman Chlíbek - Concepedia

Author

Roman Chlíbek

Also Known As

Chlibek, Roman, R Chlibek, R Chlíbek, R. Chlibek, R. Chlíbek, Roman Chlibek, Roman Chlibek (2817448), Roman Chlíbek, Stefano Torelli

130

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

University of Defence GlaxoSmithKline (Belgium)University Hospital Hradec Králové Vilnius University The University of Sydney

About

Roman Chlíbek is an author at University of Defence specializing in medicine, vaccination, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	896
2	Epidemiology	10	10	341
3	Public Health	6	6	207
4	Allergy	1	1	373
5	Gastroenterology	1	1	12

Roman Chlíbek

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Himal Lal, Anthony L. Cunningham, Olivier Godeaux, New England Journal of Medicine	2015	1.4K
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older Anthony L. Cunningham, Himal Lal, Martina Kovac, New England Journal of Medicine	2016	1K
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials Roman Prymula, Claire‐Anne Siegrist, Roman Chlíbek, The Lancet VaccinologyVaccine SafetyVaccinationPreventive MedicineVaccine Development	2009	373
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older Anthony L. Cunningham, Thomas C. Heineman, Himal Lal, The Journal of Infectious Diseases	2018	185
Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age Roman Chlíbek, J.M. Bayas, Helen Collins, The Journal of Infectious Diseases	2013	144
Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study Roman Chlíbek, Jan Smetana, Karlis Pauksens, Vaccine VaccinologyVaccinationVaccine SafetyVaccine DevelopmentVaccine Research	2014	133
Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults Roman Chlíbek, Karlis Pauksens, Lars Rombo, Vaccine	2015	121
Hepatitis A/B vaccination of adults over 40 years old: Comparison of three vaccine regimens and effect of influencing factors Marie Van der Wielen, Pierre Van Damme, Roman Chlíbek, Vaccine VaccinologyVaccine SafetyVaccinationHepatitis DViral Hepatitis	2006	95
Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults Tino F. Schwarz, Stéphanie Volpe, Grégory Catteau, Human Vaccines & Immunotherapeutics	2018	78
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois, Vaccine	2019	61

Page 1